Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Common Equity (2016 - 2025)

Historic Common Equity for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to $1.7 billion.

  • Alkermes' Common Equity rose 3415.56% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 3415.56%. This contributed to the annual value of $1.5 billion for FY2024, which is 2180.88% up from last year.
  • As of Q3 2025, Alkermes' Common Equity stood at $1.7 billion, which was up 3415.56% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Alkermes' Common Equity ranged from a high of $1.7 billion in Q3 2025 and a low of $1.0 billion during Q1 2023
  • For the 5-year period, Alkermes' Common Equity averaged around $1.2 billion, with its median value being $1.2 billion (2023).
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 649.2% in 2023, then soared by 3415.56% in 2025.
  • Quarter analysis of 5 years shows Alkermes' Common Equity stood at $1.1 billion in 2021, then decreased by 6.19% to $1.0 billion in 2022, then grew by 15.23% to $1.2 billion in 2023, then grew by 21.81% to $1.5 billion in 2024, then increased by 18.32% to $1.7 billion in 2025.
  • Its Common Equity was $1.7 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.5 billion in Q1 2025.